Company · CIK 0001445499
IPI Legacy Liquidation Co
Exchange
—
Entity type
operating
Fiscal year end
Apr 26
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-24-065453 · 165.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-036588 · 154.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-000705 · 403.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-299243 · 647.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-297146 · 153.2 KBSEC(opens sec.gov)
- SC 13D/AIMPEL PHARMACEUTICALS INC0001140361-23-056192 · 754.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-287903 · 148.5 KBSEC(opens sec.gov)
- SC 13D/AIMPEL PHARMACEUTICALS INC0001140361-23-053430 · 723.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-23-063759 · 9.0 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-277083 · 213.5 KBSEC(opens sec.gov)
Insiders
- 5AM Opportunities I (GP), LLC10% Owner
- 5AM Opportunities I, L.P.10% Owner
- 5AM Ventures V, L.P.10% Owner
- ADAMS ADRIANDirector, COB, CEO and President
- Adelman Robert J10% Owner
- Allison David D.Director
- Amin RajivVP, Controller & Interim CFO
- BAM Partners Trust10% Owner
- BROOKFIELD Corp /ON/10% Owner
- Brookfield Oaktree Holdings, LLC10% Owner
Tickers
No tickers on record.
Addresses
business
201 ELLIOTT AVE. W SUITE 260
SEATTLE, WA, 98119
mailing
201 ELLIOTT AVE. W SUITE 260
SEATTLE, WA, 98119
Former names
- IMPEL PHARMACEUTICALS INC2024-02-15
- IMPEL NEUROPHARMA INC2022-04-14
Same industry